FrancophonIA/ELRC3.0 huggingface dataset:
English: The main measure of effectiveness was the number of patients who had at least a ‘major cytogenetic response' (where the proportion of white blood cells with the Philadelphia chromosome fell below 35%) after six months of Bosulif treatment.
Croatian: Glavno mjerilo djelotvornosti bio je broj bolesnika u kojih je nakon šest mjeseci liječenja lijekom Bosulif zabilježen barem „velik citogenetski odgovor” (kada se udio bijelih krvnih stanica koje sadrže Philadelphia kromosom spusti ispod 35 %).
English: For the full list of all side effects reported with Bosulif, see the package leaflet.
Croatian: Potpuni popis nuspojava zabilježenih pri primjeni lijeka Bosulif potražite u uputi o lijeku.
English: A second study in 536 newly diagnosed CML patients in the ‘chronic phase' compared Bosulif with imatinib.
Croatian: Lijek Bosulif uspoređen je s imatinibom u drugom ispitivanju na 536 novodijagnosticiranih bolesnika s KML-om u kroničnoj fazi.
English: Subcutaneous use pre-filled syringe 1.0 ml (150 mg/ml) 3 (3 x 1) pre-filled syringes (multipack)
Croatian: 1,0 ml (150 mg/ml) 3 (3 x 1) napunjenih štrcaljki (višestruko pakiranje)
English: Subcutaneous use pre-filled pen 1.0 ml (150 mg/ml) 3 (3 x 1) pre-filled pens (multipack)
Croatian: 1,0 ml (150 mg/ml) 3 (3 x 1) napunjenih brizgalica (višestruko pakiranje)
English: Subcutaneous use pre-filled pen 1.0 ml (150 mg/ml) 1 pre-filled pen
Croatian: 1,0 ml (150 mg/ml) 1 Napunjena brizgalica
English: Subcutaneous use pre-filled syringe 1.0 ml (150 mg/ml) 1 pre-filled syringe
Croatian: 1,0 ml (150 mg/ml) 1 Napunjena štrcaljka
English: You may need to have blood checks if you take:
Croatian: Možda ćete trebati obaviti pretrage krvi ako uzimate:
English: This medicinal product should not be given to children under 18 years of age because the safety and efficacy have not yet been fully established.
Croatian: Ovaj lijek se ne smije davati djeci mlađoj od 18 godina jer sigurnost i djelotvornost nisu još u potpunosti ustanovljene.
English: The terminal elimination half-life of irbesartan is 11-15 hours.
Croatian: Krajnje poluvrijeme eliminacije irbesartana iznosi 11-15 sati.
English: ATC code: C09C A04
Croatian: ATK oznaka: C09C A04
English: Date of first authorisation: 30 October 2009 Date of latest renewal: 18 July 2014
Croatian: Datum posljednje obnove: 18. srpnja 2014.
English: You can take Irbesartan Teva with or without food.
Croatian: Irbesartan Teva može se uzimati s hranom ili bez nje.
English: Currently available data are described in sections 4.8, 5.1, and 5.2 but no recommendation on a posology can be made.
Croatian: Trenutno dostupni podaci opisani su u dijelovima 4.8, 5.1 i 5.2, međutim, nije moguće dati preporuku o doziranju.
English: See also information under the heading “Do not take Irbesartan Teva”.
Croatian: Vidjeti također informacije pod naslovom „Nemojte uzimati Irbesartan Teva“.
English: Other medicines and Irbesartan Teva
Croatian: Drugi lijekovi i Irbesartan Teva
English: (see section 5.3).
Croatian: (vidjeti dio 5.1.).
English: PVC/PVdC white opaque - aluminium blisters.
Croatian: PVC/PVdC bijeli neprozirni - aluminijski blisteri.
English: The safety and efficacy of Irbesartan Teva in children aged 0 to 18 has not been established.
Croatian: Sigurnost i djelotvornost lijeka Irbesartan Teva u djece u dobi od 0 do 18 godina nisu ustanovljene.
English: What Irbesartan Teva is and what it is used for
Croatian: Što je Irbesartan Teva i za što se koristi
English: Similar effects have been very rarely reported with irbesartan so far.
Croatian: Do sada su vrlo rijetko zabilježeni slični učinci s irbesartanom.
English: It is important that you continue to take Irbesartan Teva until your doctor tells you otherwise.
Croatian: Važno je da kontinuirano uzimate Irbesartan Teva sve dok Vam liječnik ne kaže drukčije.
English: There was no evidence of mutagenicity, clastogenicity or carcinogenicity.
Croatian: Nije bilo znakova mutagenosti, klastogenosti ili karcinogenosti.
English: Therefore, this combination is not recommended (see section 4.4).
Croatian: Ta se kombinacija, stoga, ne preporučuje (vidjeti dio 4.4.).
English: The incidence of adverse events was not related to dose (in the recommended dose range), gender, age, race, or duration of treatment.
Croatian: Incidencija štetnih događaja nije bila povezana s dozom (unutar preporučenog raspona doza), spolom, godinama starosti, rasom ili trajanjem liječenja.
English: if you are going to have an operation (surgery) or be given anaesthetics.
Croatian: ako trebate ići na operaciju (kirurški zahvat) ili trebate primiti anestetike.
English: Plasma protein binding is approximately 96 %, with negligible binding to cellular blood components.
Croatian: Vezivanje za proteine plazme iznosi oko 96%, s neznatnim vezanjem za krvne stanice.
English: Swallow the tablets with a sufficient amount of fluid (e.g. one glass of water).
Croatian: Tablete treba progutati s dovoljnom količinom tekućine (npr. jedna čaša vode).
English: • Second and third trimesters of pregnancy (see section 4.4 and 4.6).
Croatian: • Drugo i treće tromjesečje trudnoće (vidjeti dijelove 4.4. i 4.6).
English: If you get any of these symptoms or get short of breath, stop taking Irbesartan Teva and contact your doctor immediately.
Croatian: Ako dobijete bilo koji od ovih simptoma ili nedostatak zraka, prestanite uzimati Irbesartan Teva i odmah se javite liječniku.
English: The predefined blood pressure goal was ≤ 135/85 mm Hg.
Croatian: Unaprijed definirani ciljni krvni tlak bio je ≤ 135/85 mmHg.
English: Brampton Road Hampden Park, Eastbourne, East Sussex, BN22 9AG United Kingdom
Croatian: Brampton Road Hampden Park, Eastbourne, East Sussex, BN22 9AG
English: The active substance is irbesartan.
Croatian: Djelatna tvar je irbesartan.
English: There was no evidence of abnormal systemic or target organ toxicity at clinically relevant doses.
Croatian: Nije bilo znakova abnormalne sistemske toksičnosti ili toksičnosti ciljnog organa pri klinički relevantnim dozama.
English: However, there was no difference in the half-life and accumulation of irbesartan.
Croatian: Međutim, nije bilo razlika što se tiče poluvijeka i akumulacije irbesartana.
English: At 24 hours the reduction of blood pressure was 60-70 % of the corresponding peak diastolic and systolic responses at the recommended doses.
Croatian: U 24 sata snižavanje krvnog tlaka bilo je 60-70% vršnog dijastoličkog i sistoličkog odgovora pri preporučenim dozama.
English: The frequency of adverse reactions listed below is defined using the following convention: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to
Croatian: Učestalost nuspojava u nastavku teksta definira se na sljedeći način: vrlo često (≥ 1/10); često (≥ 1/100 do < 1/10); manje često (≥ 1/1.000 do < 1/100); rijetko (≥ 1/10.000 do < 1/1.000); vrlo rijetko (<
English: Irbesartan AUC and Cmax values were also somewhat greater in elderly subjects (≥ 65 years) than those of young subjects (18-40 years).
Croatian: Vrijednosti AUC i Cmax irbesartana također su bile nešto veće u starijih ispitanika (≥ 65 godina) u usporedbi s mlađima (18-40 godina).
English: Your doctor will normally advise you to stop taking Irbesartan Teva before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Irbesartan Teva.
Croatian: Vaš će Vam liječnik obično preporučiti da prestanete uzimati Irbesartan Teva prije nego što zatrudnite ili čim saznate da ste trudni te će Vam savjetovati da uzmete neki drugi lijek umjesto Irbesartana Teva.
English: Irbesartan has been studied in paediatric populations aged 6 to 16 years old but the current data are insufficient to support an extension of the use in children until further data become available (see sections 4.8, 5.1 and 5.2).
Croatian: Irbesartan je ispitivan na pedijatrijskoj populaciji u dobi od 6 do 16 godina, ali trenutni podaci nisu dostatni da bi podržali proširenje primjene na djecu, sve dok ne budu dostupni i daljnji podaci (vidjeti dijelove 4.8., 5.1. i 5.2.).
English: Irbesartan is a potent, orally active, selective angiotensin-II receptor (type AT1) antagonist.
Croatian: Irbesartan je snažan, oralno djelotvoran, selektivni antagonist receptora angiotenzina II (tip AT1).
English: Therefore, the use of irbesartan is not recommended.
Croatian: Stoga se ne preporučuje primjena irbesartana.
English: No specific information is available on the treatment of overdose with irbesartan.
Croatian: Nema dostupnih specifičnih podataka o liječenju predoziranja irbesartanom.
English: The dose may later be increased to 300 mg once daily depending on blood pressure response.
Croatian: Doza se kasnije može povećati na 300 mg jednom na dan, ovisno o vrijednostima krvnog tlaka.
English: After oral administration, irbesartan is well absorbed: studies of absolute bioavailability gave values of approximately 60-80 %.
Croatian: Nakon peroralne primjene irbesartan se dobro apsorbirao: ispitivanja apsolutne bioraspoloživosti pokazala su vrijednosti oko 60-80%.
English: When the individual components of the primary endpoint were analysed, no effect in all cause mortality was observed, while a positive trend in the reduction in ESRD and a significant reduction in doubling of serum creatinine were observed.
Croatian: Kad su se analizirale individualne komponente primarnog ishoda, nisu zabilježeni učinci na sve uzroke smrtnosti, dok je zabilježen pozitivan trend u smanjenju terminalne faze bubrežne bolesti i značajno smanjenje u udvostručavanju serumskog kreatinina.
English: Polydextrose (E1200) Titanium dioxide (E171) Hypromellose (E464) Macrogol 4000
Croatian: Film-ovojnica: polidekstroza (E1200) titanijev dioksid (E171) hipromeloza (E464) makrogol 4000
English: Epidemiological evidence regarding the risk of teratogenicity following exposure to ACE inhibitors during the first trimester of pregnancy has not been conclusive; however a small increase in risk cannot be excluded.
Croatian: Epidemiološki podaci koji se odnose na rizik od teratogenog učinka nakon uporabe ACE inhibitora tijekom prvog tromjesečja nisu bili dostatni za donošenje zaključaka; manji porast rizika, međutim, ne može se isključiti.
English: The most likely manifestations of overdose are expected to be hypotension and tachycardia; bradycardia might also occur from overdose.
Croatian: Najčešće očekivane manifestacije predoziranja su hipotenzija i tahikardija; zbog predoziranja može se pojaviti i bradikardija.
English: What you need to know before you take Irbesartan Teva Do not take Irbesartan Teva if you are allergic to irbesartan or to any of the other ingredients of this medicine (listed in section 6).
Croatian: Što morate znati prije nego počnete uzimati Irbesartan Teva Nemojte uzimati Irbesartan Teva ako ste alergični na irbesartan ili neki drugi sastojak ovog lijeka (naveden u dijelu 6).
English: Although consideration should be given to initiating therapy with 75 mg in patients over 75 years of age, dose adjustment is not usually necessary for elderly people.
Croatian: Iako za bolesnike starije od 75 godina treba razmotriti započinjanje terapije dozom od 75 mg, dozu obično nije potrebno prilagoditi u starijih osoba.
English: Patients with primary aldosteronism generally will not respond to antihypertensive medicinal products acting through inhibition of the renin-angiotensin system.
Croatian: Bolesnici s primarnim hiperaldosteronizmom općenito ne reagiraju na antihipertenzivne lijekove koji djeluju putem inhibicije renin-angiotenzinskog sustava.
English: In the 26-week open-label period of this trial the most frequent laboratory abnormalities observed were creatinine increases (6.5 %) and elevated CK values in 2 % of child recipients.
Croatian: otvorenom razdoblju ove studije, u trajanju od 26 tjedana, najčešće opažene laboratorijske abnormalnosti bile su povećana koncentracija kreatinina (6,5%) i povišene vrijednosti CK u 2% djece.
English: Such conditions should be corrected before the administration of irbesartan.
Croatian: Takva stanja treba korigirati prije primjene irbesartana.
English: HU-4042 Debrecen
Croatian: Pallagi út 13 HU-4042 Debrecen
English: This medicinal product does not require any special storage conditions.
Croatian: Lijek ne zahtjeva posebne uvjete čuvanja.
English: The maximal blood pressure lowering effect should be reached 4-6 weeks after beginning treatment.
Croatian: Maksimalan učinak na sniženje krvnog tlaka trebao bi se postići za 4-6 tjedana od početka liječenja.
English: Following oral or intravenous administration of 14C irbesartan, 80-85 % of the circulating plasma radioactivity is attributable to unchanged irbesartan.
Croatian: Nakon oralne ili intravenske primjene 14C irbesartana, 80-85% cirkulirajuće radioaktivnosti u plazmi odnosi se na nepromijenjeni irbesartan.
English: In particular, the addition of a diuretic such as hydrochlorothiazide has been shown to have an additive effect with irbesartan (see section 4.5).
Croatian: Posebice, pokazalo se da dodavanje diuretika, poput hidroklorotiazida, ima aditivni učinak s irbesartanom (vidjeti dio 4.5).
English: No dosage adjustment is necessary in elderly people.
Croatian: Stoga, nije potrebna prilagodba doze u starijih osoba.
English: How to store Irbesartan Teva Contents of the pack and other information
Croatian: Moguće nuspojave Kako čuvati Irbesartan Teva Sadržaj pakiranja i druge informacije
English: • Hypersensitivity to the active substance or to any of the excipients listed insection 6.1.
Croatian: • Preosjetljivost na djelatnu tvar ili neku od pomoćnih tvari navedenih u dijelu 6.1.
English: Available pharmacodynamic/toxicological data in rats have shown excretion of irbesartan or its metabolites in milk (for details see section 5.3).
Croatian: Dostupni farmakodinamički/toksikološki podaci iz ispitivanja na štakorima pokazali su da se irbesartan ili njegovi metaboliti izlučuju u mlijeko (za detalje vidjeti dio 5.3).
English: Irbesartan significantly reduced the relative risk in the primary combined endpoint of doubling serum creatinine, end-stage renal disease (ESRD) or allcause mortality.
Croatian: Irbesartan značajno snižava relativni rizik u primarnoj kombiniranoj mjeri ishoda udvostručenog serumskog kreatinina, terminalne faze bubrežne bolesti ili svih uzroka mortaliteta.
English: Peak plasma concentrations are attained at 1.5-2 hours after oral administration.
Croatian: Vršne koncentracije u plazmi postižu se 1,5 do 2 sata nakon oralne primjene.
English: Detailed information on this medicinal product is available on the website of the European Medicines Agency: http://www.ema.europa.eu
Croatian: Teva dostupne su na internetskoj stranici Europske agencije za lijekove: http://www.ema.europa.eu/.
English: Whilst there is no controlled epidemiological data on the risk with Angiotensin II Receptor Inhibitors (AIIRAs), similar risks may exist for this class of drugs.
Croatian: Iako ne postoje kontrolirani epidemiološki podaci o riziku kod primjene antagonista receptora angiotenzina II, slični rizici mogli bi postojati za ovu skupinu lijekova.
English: Pack size of 28 film-coated tablets in non-perforated calendar blisters.
Croatian: Pakiranje sa 28 filmom obloženih tableta u neperforiranim kalendarskim blisterima.
English: There is no experience regarding the administration of irbesartan in patients with a recent kidney transplantation.
Croatian: Nema iskustava s primjenom irbesartana u bolesnika kojima je nedavno transplantiran bubreg.
English: In vitro studies indicate that irbesartan is primarily oxidised by the cytochrome P450 enzyme CYP2C9; isoenzyme CYP3A4 has negligible effect.
Croatian: In vitro ispitivanja upućuju da se irbesartan primarno oksidira pomoću enzima CYP2C9 citokroma P450; izoenzim CYP3A4 ima neznatan učinak.
English: As with similar medicines, rare cases of allergic skin reactions (rash, urticaria), as well as localised swelling of the face, lips and/or tongue have been reported in patients taking irbesartan.
Croatian: Kao i kod ostalih sličnih lijekova, zabilježeni su rijetki slučajevi alergijskih kožnih reakcija (osip, urtikarija), kao i lokalizirano oticanje lica, usnica i/ili jezika kod bolesnika koji su uzimali irbesartan.
English: There is no clinically important effect on serum uric acid or urinary uric acid secretion.
Croatian: Nema klinički važnog učinka na mokraćnu kiselinu u serumu ili na urinarno izlučivanje mokraćne kiseline.
English: Irbesartan Teva is unlikely to affect your ability to drive or use machines.
Croatian: Irbesartan Teva ne bi trebao utjecati na Vašu sposobnost upravljanja vozilima i strojevima.
English: If a child swallows some tablets, contact your doctor immediately.
Croatian: Ako dijete proguta tablete, odmah se javite svom liječniku.
English: The total body and renal clearance are 157-176 and 3-3.5 ml/min, respectively.
Croatian: Ukupni tjelesni klirens iznosi 157-176, a bubrežni klirens 3-3,5 ml/min.
English: Teva Pharmaceuticals Ireland L-Irlanda
Croatian: Malta Teva Pharmaceuticals Ireland
English: While this is not documented with irbesartan, a similar effect should be anticipated with angiotensin-II receptor antagonists.
Croatian: Iako to još nije potvrđeno za irbesartan, sličan učinak može se očekivati s antagonistima receptora angiotenzina II.
English: arthralgia, myalgia (in some cases associated with increased plasma creatine kinase levels), muscle cramps
Croatian: artralgija, mijalgija (u nekim slučajevima povezana s povećanom koncentracijom kreatin kinaze u plazmi), grčevi mišića
English: Irbesartan Teva is not recommended for mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to breast-feed, especially if your baby is newborn, or was born prematurely.
Croatian: Irbesartan Teva ne preporučuje se majkama koje doje, a Vaš liječnik može izabrati drugu terapiju ako želite dojiti, osobito ako se radi o dojenju novorođenčeta ili nedonoščeta.
English: Teva Denmark A/S Tlf: +45 44985511
Croatian: Danmark Teva Denmark A/S Tlf: +45 44985511
English: potassium supplements salt substitutes containing potassium potassium-sparing medicines (such as certain diuretics) medicines containing lithium
Croatian: nadomjeske kalija nadomjeske soli koji sadrže kalij lijekove koji čuvaju kalij (kao što su neki diuretici) lijekove koji sadrže litij
English: Fertility and reproductive performance were not affected in studies of male and female rats even at oral doses of irbesartan causing some parental toxicity (from 50 to 650 mg/kg/day), including mortality at the highest dose.
Croatian: Nije zabilježen utjecaj na plodnost i reproduktivnu učinkovitost u istraživanjima na mužjacima i ženkama štakora, čak ni pri oralnim dozama irbesartana koje su uzrokovale određenu parentalnu toksičnost (doze od 50 do 650 mg/kg/dan), uključujući mortalitet pri najvišim dozama.
English: As with any antihypertensive agent, excessive blood pressure decrease in patients with ischaemic cardiopathy or ischaemic cardiovascular disease could result in a myocardial infarction or stroke.
Croatian: Kao i kod bilo kojeg antihipertenziva, prekomjerni pad krvnog tlaka u bolesnika s ishemijskom kardiopatijom ili ishemijskom kardiovaskularnom bolesti može dovesti do infarkta miokarda ili moždanog udara.
English: Close monitoring of serum potassium in patients at risk is recommended (see section 4.5).
Croatian: Preporučuje se česta kontrola serumskog kalija u rizičnih bolesnika (vidjeti dio 4.5.).
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS CALENDAR BLISTER
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP KALENDARSKI BLISTER
English: Limited accumulation of irbesartan (< 20 %) is observed in plasma upon repeated once-daily dosing.
Croatian: Ograničena akumulacija irbesartana (< 20%) zabilježena je u plazmi nakon primjene opetovanih doza jedanput na dan.
English: Debrecen H-4042
Croatian: Pallagi út 13 Debrecen H-4042
English: Irbesartan Teva belongs to a group of medicines known as angiotensin-II receptor antagonists.
Croatian: Irbesartan Teva pripada skupini lijekova koja se naziva antagonisti receptora angiotenzina II.
English: IDNT was a double blind, controlled, morbidity and mortality trial comparing irbesartan, amlodipine and placebo.
Croatian: kontrolirana studija morbiditeta i mortaliteta u kojoj su uspoređivani irbesartan, amlodipin i placebo.
English: Patients were titrated from 75 mg to a maintenance dose of 300 mg irbesartan, from 2.5 mg to 10 mg amlodipine, or placebo as tolerated.
Croatian: Bolesnici su titrirani od 75 mg do doze održavanja od 300 mg irbesartana, od 2,5 mg do 10 mg amlodipina ili placeba do granice podnošljivosti.
English: Diuretics and other antihypertensive agents
Croatian: Diuretici i drugi antihipertenzivni lijekovi
English: If you accidentally miss a daily dose, just take the next dose as normal.
Croatian: Ako ste zaboravili uzeti Irbesartan Teva Ako slučajno zaboravite uzeti dnevnu dozu, uzmite sljedeću dozu kao što to obično i činite.
English: Contents of the pack and other information What Irbesartan Teva contains
Croatian: Sadržaj pakiranja i druge informacije Što Irbesartan
English: Lithium The combination of lithium and irbesartan is not recommended (see section 4.5).
Croatian: Ne preporučuje se kombinacija litija i irbesartana (vidjeti dio 4.5.).
English: Always take this medicine exactly as your doctor has told you.
Croatian: Uvijek uzmite Irbesartan Teva točno onako kako Vam je rekao Vaš liječnik.
English: Irbesartan at a dose of 150 mg once daily generally provides a better 24 hour blood pressure control than 75 mg.
Croatian: Doza od 150 mg irbesartana jedanput na dan općenito osigurava bolju kontrolu krvnog tlaka nego doza od 75 mg u razdoblju od 24 sata.
English: Do not use this medicine after the expiry date that is stated on the outer carton or foil after EXP.
Croatian: Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na kutiji ili blisteru iza oznake „EXP“.
English: • Tablet coating: polydextrose, titanium dioxide, hypromellose and macrogol 4000.
Croatian: • Ovojnica tablete: polidekstroza, titanijev dioksid, hipromeloza i makrogol 4000.
English: It is unknown whether irbesartan or its metabolites are excreted in human milk.
Croatian: Nije poznato izlučujuju li se irbesartan ili njegovi metaboliti u majčino mlijeko u ljudi.
English: When irbesartan is used in patients with impaired renal function, a periodic monitoring of potassium and creatinine serum levels is recommended.
Croatian: Kad irbesartan uzimaju bolesnici s oštećenom funkcijom bubrega, preporučuje se periodički kontrolirati serumske razine kalija i kreatinina.
English: Discontinuation due to any clinical or laboratory adverse event was less frequent for irbesartan-treated patients (3.3 %) than for placebo-treated patients (4.5 %).
Croatian: Prekid terapije zbog određenih kliničkih ili laboratorijskih štetnih događaja bio je manje čest u bolesnika liječenih irbesartanom (3,3%) nego u skupini bolesnika koji su primali placebo (4,5%).
English: if you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren
Croatian: ako imate šećernu bolest ili oštećenu bubrežnu funkciju i liječite se lijekom za snižavanje krvnog tlaka koji sadrži aliskiren
English: Other antihypertensive agents may increase the hypotensive effects of irbesartan; however irbesartan has been safely administered with other antihypertensive agents, such as beta-blockers, long-acting calcium channel blockers, and thiazide diuretics.
Croatian: Drugi antihipertenzivi mogu pojačati hipotenzivni učinak irbesartana; irbesartan se, međutim, pokazao sigurnim za primjenu s ostalim antihipertenzivnim lijekovima poput beta blokatora, dugodjelujućih blokatora kalcijevih kanala i tiazida.
English: The following presents the adverse drug reactions that were reported in placebo-controlled trials in which 1,965 hypertensive patients received irbesartan.
Croatian: Sljedeća tablica prikazuje nuspojave prijavljene u placebom kontroliranim ispitivanjima, u kojima je 1965 hipertenzivnih bolesnika primalo irbesartan.